Arrhythmia-induced Cardiomyopathy (AiCM)

2

Review clinical trials related to Arrhythmia-induced Cardiomyopathy (AiCM). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy

The goal of this observational study is to learn about the genetic insights of arrhythmya-induced cardiomyopathy and its clinical prognosis. The main questions it aims to answer are: I. Does patients with arrhythmia-induced cardiomyopathy have a greater proportion of genetic mutations compared with other types of cardiomyopathy or general population? II. Have the genetics any prognostic impact in patients with arrhythmia-induced cardiomyopathy?

Participants needed: 109
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Hospital Universitario 12 de OctubreUpdated: May 14, 2025Locations: 4Duration: 1 Year
Eligibility criteria

Presence of atrial fibrillation or atrial flutter not self-limited. [+3]

Refusal of informed consent. [+12]

Status: Recruiting

Characterization of Arrhythmia-induced Cardiomyopathy

The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.

Participants needed: 2,700
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, Basel, SwitzerlandUpdated: Mar 4, 2025Locations: 1
Eligibility criteria

Diagnostic or suspicion of AiCM as presence of specified keyword in patient's fi... [+1]

Patient's active refusal of the general consent of the University Hospital Basel [+8]